A study following people with brain tumors treated with STaRT (GammaTiles)

Official title: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.

The trial team last updated this record on .

The short version

This study collects information on how people with brain tumors do after treatment with STaRT, also called GammaTiles.

Read our full plain-language summary

What the trial team says

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

From the trial's own listing on ClinicalTrials.gov.

Key facts

Registry number
NCT04427384
Conditions studied
Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma

Where it is running

This trial lists 54 sites.

How to use this

Talk to your care team first. They know your history and can tell you whether this trial is worth your time.

Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.

See the full listing on ClinicalTrials.gov

This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.